from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3545c/cyp125

LFCtreatmentdescriptionclass of inhibitor

-0.007

Amikacinug/mL Amikacintranslation

0.193

Cap5-10ug/mL Capreomycintranslation

-0.314

Rox10-50 ug/mL Roxithromycintranslation

0.289

SM2-5 ug/mL Streptomycintranslation

0.247

Tet5-10 ug/mL Tetracyclinetranslation

0.317

Rif0.2-5ug/mL Rifampicintranscription

-0.257

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.334

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.403

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.757

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.529

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.360

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.304

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.293

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.017

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.298

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.634

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.864

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.324

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.780

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.206

KCN5-20 ug/mL Potassium cyaniderespiration

-0.477

NaN30.2-2 mM Sodium aziderespiration

-0.484

Nigericin50 uM Nigericinrespiration

1.371

TRC10-150 ug/mL Triclosanrespiration

-0.688

TRZ10-25 ug/mL Thioridazinerespiration

0.479

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.839

menadione6-10 ug/mL Menadionerespiration

2.925

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.649

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.185

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.713

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.522

NRP_1Non-replicating persistence stage 1dosRassociated

-0.470

Amp0.2mg/mL AmpicillincellWall

-0.501

Cephalexin20-100 ug/mL CephalexincellWall

-0.160

Cerulenin0.32-5 ug/mL CerulenincellWall

0.079

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.226

EMB10-20 ug/mL EthambutolcellWall

-0.071

Eta12-40 ug/mL EthionamidecellWall

-0.185

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.167

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.235

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.067

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.248

BZA0.12 mg/mL BenzamidearomaticAmides

0.292

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.758

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.145

H2O24 mM hydrogen peroxideDNAdamaging

-0.171

Levo10 ug/mL LevofloxacinDNAdamaging

-0.628

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.800

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.070

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.504

UVUV-irradiationDNAdamaging

0.474

ARP41-4 ug/mL Antitubercular compound ARP4?

0.182

Antimycin12.5-50 ug/mL Antimycin A?

-0.465

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.039

PA_110-50 ug/mL Antitubercular compound PA-1?

0.197

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.230

PA8240.2-2 ug/mL PA-824?

1.560

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.077

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.343

Verapamil50 uM Verapamil?

-0.870

mercaptoethanol2 mM 2-Mercaptoethanol?

0.314

methoxatin10-20 ug/mL Methoxatin?